XML 17 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Operating activities:    
Net income $ 782 $ 699
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 107 97
Provision for loan losses 17 44
Deferred loan origination costs (64) (10)
Amortization of premium on investments 495 535
Proceeds from sale of loans 6,188 2,517
Loans disbursed for sale in the secondary market (6,827) (3,065)
Gain on sale of loans (220) (90)
Amortization of intangible asset 30 30
Amortization of acquisition-related loan yield adjustment (33) (44)
Gain on sale of other real estate owned (79) (6)
Provision for loss on real estate owned 0 24
Gain recognized from death benefit on bank owned life insurance 0 (68)
Increase in cash surrender value of life insurance (120) (128)
Stock-based compensation 63 65
Amortization of ESOP shares 118 112
Deferred income taxes 125 (109)
Effects of change in operating assets and liabilities:    
Accrued interest receivable 115 (74)
Prepaid expenses and other assets (59) 338
Accrued interest payable (2) 2
Accrued expenses and other (1,544) (109)
Net cash provided by (used in) operating activities (908) 760
Investing activities:    
Proceeds from maturity of available for sale investment securities 280 45
Proceeds from maturity of held to maturity securities 30 27
Proceeds from sale of available for sale investment securities 6,935 0
Proceeds from repayment of mortgage-backed securities and collateralized mortgage obligations available for sale 5,524 6,165
Proceeds from sale of mortgage-backed securities available for sale 11,087 8,645
Purchases of available for sale investment securities (9,885) 0
Purchases of held to maturity investment securities 0 (388)
Purchases of mortgage-backed securities available for sale (10,943) 0
Proceeds from bank owned life insurance death benefit 0 446
Net increase in loans (5,958) (9,702)
Capital expenditures (16) 0
Net cash provided by (used in) investing activities (2,946) 5,238
Financing activities:    
Net increase (decrease) in deposits 3,089 (1,341)
Dividends paid to stockholders (252) (275)
Repurchases of common stock 0 (1,128)
Net increase in advances from borrowers for payment of insurance and taxes 210 221
Net cash provided by (used in) financing activities 3,047 (2,523)
Net increase (decrease) in cash and cash equivalents (807) 3,475
Cash and cash equivalents at beginning of period 28,980 18,522
Cash and cash equivalents at end of period $ 28,173 $ 21,997